Connexin43 as a Tumor Suppressor: Proposed Connexin43 mRNA-circularRNAs-microRNAs Axis Towards Prevention and Early Detection in Breast Cancer

dc.contributor.authorNaser Al Deen, Nataly
dc.contributor.authorAbouHaidar, Mounir Georges
dc.contributor.authorTalhouk, Rabih S.
dc.contributor.departmentDepartment of Biology
dc.contributor.facultyFaculty of Arts and Sciences (FAS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:20:48Z
dc.date.available2025-01-24T11:20:48Z
dc.date.issued2019
dc.description.abstractBreast cancer (BC) is a global public health burden, constituting the highest cancer incidence in women worldwide. Connexin43 (Cx43) is a member of a family of transmembrane proteins responsible in part for intercellular communication between adjacent breast epithelial cells, via gap junctions. Cx43 plays key role in mammary gland development and differentiation and its spatio-temporal perturbation contributes to tumorigenesis. Thus, Cx43 acts as a breast tumor-suppressor. Signaling pathways and phenotypes downstream of Cx43 mRNA loss/mis-localization in breast cells have been well-studied. However, axes parallel to Cx43 loss are less understood. microRNAs (miRNAs) are small endogenous non-coding RNAs that repress translation and circularRNAs (circRNAs) are a class of endogenous RNAs that originate from RNA splicing and act as miRNA “sponges”. CircRNAs and miRNAs are dysregulated in cancers and are highly abundant and stable in the circulation. Thus, they present as attractive liquid biopsy cancer biomarkers. Here, an axis for Cx43 mRNA-circRNAs-miRNAs interactions along BC initiation (denoted by loss of breast epithelial polarity and development of hyperplastic phenotypes) is proposed to potentially serve as a signature biomarker toward BC early-onset detection and prevention. © Copyright © 2019 Naser Al Deen, AbouHaidar and Talhouk.
dc.identifier.doihttps://doi.org/10.3389/fmed.2019.00192
dc.identifier.eid2-s2.0-85072733350
dc.identifier.urihttp://hdl.handle.net/10938/25141
dc.language.isoen
dc.publisherFrontiers Media S.A.
dc.relation.ispartofFrontiers in Medicine
dc.sourceScopus
dc.subjectBiomarkers
dc.subjectBreast cancer
dc.subjectCircularrnas
dc.subjectConnexins
dc.subjectGap junctions
dc.subjectMicrornas
dc.subjectPrevention
dc.subjectTumor-suppressors
dc.subjectBiological marker
dc.subjectCircular rna
dc.subjectConnexin 43
dc.subjectMessenger rna
dc.subjectMicrorna
dc.subjectRna
dc.subjectTumor marker
dc.subjectUnclassified drug
dc.subjectBiogenesis
dc.subjectCancer prevention
dc.subjectEarly diagnosis
dc.subjectHuman
dc.subjectLiquid biopsy
dc.subjectMammary gland
dc.subjectReview
dc.titleConnexin43 as a Tumor Suppressor: Proposed Connexin43 mRNA-circularRNAs-microRNAs Axis Towards Prevention and Early Detection in Breast Cancer
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019-7334.pdf
Size:
1000.91 KB
Format:
Adobe Portable Document Format